Navigation Links
Tumor cell vaccination trial to promote anti-leukemia responses
Date:8/5/2013

Chronic lymphocytic leukemia (CLL) is a cancer of the blood and bone marrow that most often affects older adults. CLL responds to bone marrow stem cell transplantation (allo-HSCT); however, the rate of relapse for CLL remains relatively high. A benefit of allo-HSCT is that treatment can result in the development of an anti-tumor response produced by the grafted cells and is associated with a low risk of cancer relapse.

In this issue of the Journal of Clinical Investigation, Catherine Wu and colleagues at the Dana Farber Cancer Institute in Boston report the results of a clinical trial that tested the effectiveness of vaccination with a CLL patient's own leukemia cells in the development of anti-tumor responses and relapse reduction. Patients with advanced CLL were vaccinated with their own irradiated tumor cells following allo-HSCT. Nearly 3 years after vaccination, 13 of the 18 vaccinated patients were in complete remission. The 6 patients that received the maximum vaccine dosage produced T cells that specifically reacted against tumors cells.

These results suggest that tumor cell vaccination has the potential to enhance anti-tumor responses following allo-HSCT.


'/>"/>

Contact: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related medicine news :

1. Immune system molecule promotes tumor resistance to anti-angiogenic therapy
2. Suffocating tumors could lead to new cancer drugs
3. Digital PCR technology detects brain-tumor-associated mutation in cerebrospinal fluid
4. Protein complex linked to cancer growth may also help fight tumors, Moffitt researchers say
5. Voices Against Brain Cancer Comments on Discovery of Nano Drug That May Aid in Treatment of Brain Tumors
6. Compounds outsmart solid tumors malfunctioning machinery
7. Nano drug crosses blood-brain tumor barrier, targets brain-tumor cells and blood vessels
8. Self-perpetuating signals may drive tumor cells to spread
9. Suspicions confirmed: Brain tumors in children have a common cause
10. American Brain Tumor Association Conference to Help Patients/Caregivers Map Road to Wellness
11. Removal of tumor-associated immune cell protein decreases tumor progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... Viejo, CA (PRWEB) , ... May 02, 2016 , ... ... in Final Cut Pro X. Pick and choose from a variety of electric styles ... with color swabs. Users can customize shadow, dof blur, three dimensional rotation, and much ...
(Date:5/2/2016)... ... 02, 2016 , ... The Civilian Corps of the U.S. Army Medical Command ... care for its uniformed service members, the retired service members, their families and other ... through May 12th National Nurses Week. It acknowledges the hard work and dedication of ...
(Date:5/2/2016)... DC (PRWEB) , ... May 02, 2016 , ... ... Results and Data Book for the 2016 Main Residency Match® (“the Match”), the ... positions in United States teaching institutions. A record-high 30,750 positions were placed in ...
(Date:5/2/2016)... ... May 02, 2016 , ... MedPro Waste Disposal, LLC (MedPro) is ... MedPro now offers its mail back service for an all-inclusive rate. MedPro Disposal President, ... to provide service to all of the clients in the country who are looking ...
(Date:5/2/2016)... ... 02, 2016 , ... Visceral fat, also known as “deep ... liver and pancreas. If not properly addressed, visceral fat can lead to serious ... Medical Oncology and Palliative Care, warns against the dangers of visceral fat. “Just ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Treato , the single ... today that it has been named a Cool Vendor ... Life Sciences, 2016, Stephen Davies , ... on life-science- oriented analytics, algorithms and smart machine technology ... confirm medication ingestion, and analyze unstructured information.   ...
(Date:4/28/2016)... 2016  ValGenesis, Inc., the market leader ... today announced that a prominent world provider ... chronic kidney failure has selected ValGenesis Validation ... validation process. The global medical device manufacturer ... manage their validation processes electronically. Upon completion ...
(Date:4/27/2016)... 27 Avril 2016   ... de +5% sur le trimestre, soutenu par une ... Croissance de +16% des ventes aux ... Mauna Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), ... annonce aujourd,hui son chiffre d,affaires pour le premier ...
Breaking Medicine Technology: